Notícias
Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.
105last 24h
3127last 7d
510● bullish (7d)
311● bearish (7d)
227publishers
24/7 Wall St.39d agobearish
Moderna Sinks 6% on Citi Downgrade; Merck and Pfizer Stay FlatBarrons.com39d agobearish
Moderna Stock Has Run Too Far, Too Fast. Why Citi Just Downgraded It to Sell.24/7 Wall St.74d agobearish
Moderna Drops 7% Despite a Fresh Wolfe Research Upgrade, BioNTech Slips24/7 Wall St.76d agoneutral
Pfizer Stock: Wall Street Sees a Rebound, Here’s Our Price TargetSimply Wall St.87d agoneutral
Merck (MRK) Stock Looks Fully Valued Following Raised Revenue OutlookSimply Wall St.93d agoneutral
Merck (MRK) Could Be 3% Undervalued On Raised Outlook And Key Drug ApprovalsInsider Monkey159d agobullish
H.C. Wainwright Maintains Buy Rating on Tempus AI (TEM) Following Strong Revenue GrowthInsider Monkey180d agoneutral
Analyst Reinstates Merck (MRK) with ‘Neutral’ Rating, $125 Price TargetInsider Monkey186d agobullish
Analyst Raises Merck (MRK) Price Target by $1 After Beating Q1 Estimates